复发型多发性硬化症(relapsing-remitting MS)是一种神经系统方面的疾病,急性发作之后,经过一小段恢复期,会反复发作,患者若不及时治疗,甚至诊断确认后九个月都还未加以治...
基于4个网页-相关网页
Therapies are currently available for relapsing-remitting MS, secondary progressive MS and progressive relapsing MS.
目前有针对复发-缓解型,继发-进展型,与进展-复发型多发硬化症的治疗方案。
The most common type is relapsing-remitting MS, in which patients experience attacks of symptoms such as muscle weakness and spasms followed by periods of symptom-free remission.
最常见的类型是“复发-缓解型多发性硬化”,即病人在症状发作后,如肌无力和肌痉挛,有一段症状完全缓解的期间。
They can reduce the incidence of relapse or extend time between relapses in the relapsing-remitting form of MS but symptoms are not changed by the drugs.
它们能够降低医学倒退的发生率或者延缓倒退-抵消相转换的医学形式,但是,药物并不能够改变这些症候。
The United States Food and Drug Administration has approved 3 forms of beta interferon for treatment of Relapsing-Remitting MS.
VOA: special.2009.01.06
It begins to affect them several years after they have had Relapse-Remitting MS.
VOA: special.2009.01.06
This form of the disease affects about 50% of those with the Relapse-Remitting form of MS.
VOA: special.2009.01.06
应用推荐